Regimen-specific genomic signatures are able to predict response to chemotherapy regimens among patients with estrogen-receptor-negative breast cancer. Medscape Medical News
Treatment with infliximab modulates the levels of several biomarkers in patients with ankylosing spondylitis (AS), according to a report in the April Annals of the Rheumatic Diseases. Reuters Health Information
A case-control study showed that bilateral and persistent cryptorchidism was associated with genetic mutations, including Klinefelter syndrome and INSL3 receptor gene mutations. Medscape Medical News
